Axis-W Pharma AB is a Swedish AB based in Stockholm, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2024, the company has 0 employees.
Solidity ratio Equity ÷ Total assets × 100 Among the 20% lowest rated companies in the industry
2025 2025
Liquidity ratio Current assets ÷ Short-term debt Among the 10% lowest rated companies in the industry
2025 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 Among the 40% lowest rated companies in the industry
2025 2025
Key figures Annual report 2025 Gross profit — — EBITDA 0K SEK — Net profit 0K SEK — Total assets 241.1K SEK — Equity 25K SEK — Employees 0 —
Legal name
Axis-W Pharma AB
Founded
20 December 2024 · 1 year
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Utveckling, forskning, produktion och försäljning av läkemedel.
(no translation available)
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development The bottom line showed a break-even result.
At the end of 2025, equity financed 10.4% of the balance sheet, and current assets covered short-term debt 0.2 times.
Frequently asked questions What is the Org number of Axis-W Pharma AB? Axis-W Pharma AB is registered with Bolagsverket / SCB under Org 5595125914.
Who is the chairman of Axis-W Pharma AB? Nils Göran Gutberg chairs the board of Axis-W Pharma AB.
Where is Axis-W Pharma AB headquartered? Axis-W Pharma AB's registered address is Djurgårdsslätten 92.
